Founta Christina

Education & Academic Qualifications


  • Trained and certified for performing medical clinical trials (Good Clinical Practice – GCP)
  • Trained in Practical Statistics for Medical Research UCL, London Apr 2014
  • Supervision of junior colleagues in research as a senior researcher
  • Deputy Principal Investigator for Guy’s & St Thomas’ NHS trust for a Randomised Clinical Trial on HPV vaccination after excisional treatment for CIN (NOVEL trial – NIHR Portofolio study sponsored by Imperial College, London)

Past activity:

  • Coordinator and committee member of the national BSVVD guidelines development group for VIN
  • Clinical advisor in redesigning regional follow up for gynaecological oncology patients (regional 3 year project, NGOC)
  • Collaboration with the London School of Health and Tropical Medicine for a National study on identifying performance indicators for the management of patients with gynaecological cancer and using them for standardizing and improving quality of care
  • Founding member of the British Group of Gynaecological Oncology trainees for surgical clinical trials


  • Ptychion Iatrikes, Athens Medical School, National & Kapodistrian University of Athens, 2005
  • PhD, Ioannina Medical School, 2016
  • British Society of Colposcopy & Cervical Pathology (BSCCP) accredited colposcopist (2014) & trainer (2016)

PhD/ Thesis

«Cervical healing and future obstetric outcomes following excisional treatment for CIN in correlation with exact percentage of cervical tissue excised»

Under the Supervision of: Prof E Paraskevaidis: Professor in Obstetrics & Gynaecology, University Hospital of Ioannina, Greece

Pass Mark: Excellent

Board Member

  • British Society of Colposcopy & Cervical Pathology (BSCCP) member since 9/2011

  • Royal College of Obstetricians & Gynaecologists (RCOG) associate member since 11/2012

  • British Gynaecological Cancer Society (BGCS) member since 1/2014

  • British Society of Gynaecological Endoscopy (ΒSGE) BSGE member since 5/2014

  • Hellenic Society of Colposcopy & Cervical Pathology (HSCCP) accredited colposcopist

Editorial Boards

AD-HOC REVIEWER for peer-reviewed international journals

  • British Journal of Obstetrics & Gynaecology (BJOG)

  • American Journal of Obstetrics & Gynaecology (AJOG)

  • European Journal of Obstetrics & Gynaecology (EJOG)

  • Medicine

Professional Experience

  • Consultant Gynaecologist in Gynaecological Cancer Diagnostics & Colposcopy Lead, Guy’s & St Thomas’ NHS Trust, London, UK from 5/2019 to date

  • Consultant Gynaecologist & Gynaecological Oncology Diagnostics Lead, Musgrove Park Hospital, Taunton, UK from 4/2017 to 5/2019

  • Clinical Fellow in Gynaecological Oncology, Musgrove Park Hospital, Taunton, UK αfrom 8/2015 to 4/2017

  • Gynaecological Oncology Clinical Research Fellow, Northern Gynaecological Oncology Centre, Gateshead, UK from 1/2013 to 7/2015

Education Experience

  • Co-lead & Trainer, DySIS colposcopy workshops, NGOC, Gateshead

  • Preceptor visits for consultant gynaecologists on the use of DySIS colposcopy, MPH, Taunton, UK

  • Faculty / invited speaker, RCOG Basic Colposcopy Course, London since February 2015

  • Working with King’s college London for the education of Gynaecologists in India on early diagnosis of gynaecological cancers


Clinical and Research Interest

Clinical Interest:

  • Gynaecological Oncology

  • Gynaecological Cancer Diagnostics

  • Colposcopy & Cervical Pathology

  • Hysteroscopy

  • Surgical Gynaecology

Research Interest: 

Participation in numerous Clinical studies, both as a lead investigation and as member of the research team in Greece and the UK:

  • Assessment of the accuracy of DySIS colposcopy in different patient groups

  • Developing optimum follow-up strategies after treatment of CIN

  • The value of HE4 for the assessment of women with abdominal symptoms and/or an ovarian mass

  • Imaging and volumetry methods of the uterine cervix and assessment of its healing capacity following treatment for CIN

  • Systematic review of the literature on gynaecological oncology services / outcomes in the context of assessing the need for a major system re-organization

  • HPV vaccination after excisional treatment for CIN

  • The use of microbubbles in identifying sentinel nodes for vulval cancer patients


Best Oral Presentation:

  • “The role of Dynamic Spectral Imaging (DySIS) in the colposcopic assessment of cytology negative failed Test Of Cure patients: Results of a pilot study” C Founta, N Ratnavelu, M Bradbury, S Natsis, R O’Donnell, A Feusi, A Kucukmetin, C Ang, A Fisher, R Naik BSCCP annual meeting, 15-17th April 2015, Nottingham, UK

  • “Effect of condom use on HPV status after conservative treatment for CIN” Valasoulis, C. Founta, M. Kyrgiou, O. Valari, I. Tsoumpou, A. Loufopoulos, P. Karakitsos, G. Koliopoulos, E Paraskevaidis and Hellenic Cervical Pathology Academic Group (HECPA Group) 6th Panhellenic Congress of Cervical Pathology and Colposcopy, November 2010, Ioannina, Greece

  • “Expression of HPV-related biomarkers in association with the grade of cervical intraepithelial lesion” G Valasoulis, S Stasinou, M Kyrgiou, M Nasioutziki, I Tsoumpou, C Founta, P Karakitsos, G Koliopoulos, E Paraskevaidis (UK, Greece) 9th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists, September 28-30, 2011 in Athens, Greece

  • Long-term data on the trend of hpv-related biomarkers post-treatment for cervical intra-epithelial lesions” Valasoulis, SM. Stasinou, M. Kyrgiou, E. Bilirakis, K. Karampotsis, C. Founta, A. Loufopoulos, V. Malamou-Mitsi, G. Koliopoulos, P. Karakitsos, E. Paraskevaidis & the HeCPA study Group International Course in Colposcopy and Cervical Pathology, November 10-12 2011, Ioannina, Greece

  • “Proportion of excision, cervical healing and pregnancy outcomes after Large Loop Excision of the Transformation Zone for Cervical Intraepithelial Neoplasia” Kyrgiou, G. Valasoulis, SM Stasinou, C. Founta, P Martin-Hirsch, A. Daponte, M. Arbyn, W. Prendville, E. Bilirakis, S, Tzioras, N. Plachouras, A. Loufopoulos, R. Naik, P. Bennett, S. Ghaem-Maghami, D. Lyons, E. Paraskevaidis and the HeCPA study Group International Course in Colposcopy and Cervical Pathology, November 8-10 2012, Ioannina, Greece


HPV Vaccines, Medical Students Textbook, Medical School, University of Ioannina 3rd edition, 2010

Recent Publications

  • Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation. Weston G, Dombrowski C, Harvey MJ, Iftner T, Kyrgiou M, Founta C, Adams EJ. BMJ Open. 2020 Mar 8;10(3):e031303. doi: 10.1136/bmjopen-2019-031303.


  • Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis. Tranoulis A, Georgiou D, Founta C, Mehra G, Sayasneh A, Nath R. Int J Gynecol Cancer. 2020 Jan;30(1):107-114. doi: 10.1136/ijgc-2019-000868. Epub 2019 Dec 3.


  • Erratum to “Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes”[Int J Gynecol Obstet 128(2015) 141-147]. Kyrgiou M, Valasoulis G, Stasinou SM, Founta C, Athanasiou A, Bennett P, Paraskevaidis E. Int J Gynaecol Obstet. 2019 Sep;146(3):392. doi: 10.1002/ijgo.12905. Epub 2019 Jul 19.

  • Standardized Digital Colposcopy with Dynamic Spectral Imaging for Conservative Patient Management. Kaufmann A, Founta C, Papagiannakis E, Naik R, Fisher A. Case Rep Obstet Gynecol. 2017;2017:5269279. doi: 10.1155/2017/5269279. Epub 2017 Dec 25.

  • Diagnostic accuracy of colposcopy with dynamic spectral imaging for cytology-negative/high-risk HPV positive (failed test of cure) after large loop excision of the transformation zone (LLETZ) of the cervix: Results of the DySIS colposcopy 1 study. Founta C, Papagiannakis E, Ratnavelu N, Feusi A, Natsis S, Bradbury M, Fisher A, Naik R. Medicine (Baltimore). 2018 Jan;97(1):e9560. doi:10.1097/MD.0000000000009560.

  • Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. Ratnavelu ND, Brown AP, Mallett S, Scholten RJ, Patel A, Founta C, Galaal K, Cross P, Naik R. Cochrane Database Syst Rev.2016Mar1;3:CD010360.doi:10.1002/14651858.CD010360.pub2. Review.

  • Patient Support Groups Identifying Clinical Equipoise in UK Gynaecological Oncology Surgeons as the Basis for Trials in Ultraradical Surgery for Advanced Ovarian Cancer. Naik R, Bayne L,Founta C, Kehoe S, Rustin G, Fotopoulou C. Int J Gynecol Cancer. 2016 Jan;26(1):91-4. doi: 10.1097/IGC

  • Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy. Bradbury M,Founta C, Taylor W, Kucukmetin A, Naik R, Ang C. Int J Gynecol Cancer. 2015 Aug 4.

  • Histology verification demonstrates that biospectroscopy analysis of cervical cytology identifies underlying disease more accurately than conventional screening: removing the confounder of discordance. Gajjar K, Ahmadzai AA, Valasoulis G, Trevisan J,Founta C, Nasioutziki M, Loufopoulos A, Kyrgiou M, Stasinou SM, Karakitsos P, Paraskevaidis E, Da Gama-Rose B, Martin-Hirsch PL, Martin FL. PLoS One. 2014 Jan 3;9(1):e82416. doi: 10.1371/journal.pone.0082416

  • Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. Founta C, Arbyn M, Valasoulis G, Kyrgiou M, Tsili A, Martin-Hirsch P, Dalkalitsis N, Karakitsos P, Kassanos D, Prendiville W, Loufopoulos A, Paraskevaidis E. BJOG 2010; 117(12):1468-74